Mon, Jan 5: A BC company is in the final stages of testing a simple new way of detecting cancer. Elaine Yong reports.
Source: Global News http://globalnews.ca/video/1756747/richmond-company-develops-urine-cancer-test
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Form 7 Monthly Progress Report April 2024 Name of Listed Issuer: Trading Symbol: Number of
BIOMARK TO ADVANCE DEVELOPMENT OF CANCER TREATMENT FOR GLIOBLASTOMA The Company secured collaborative research funding
Form 7 Monthly Progress Report January 2024 Name of Listed Issuer: Trading Symbol: Number of
Vancouver, British Columbia – (February 28, 2024) – BioMark Diagnostics Inc. (“BioMark” or the “Company”)
Vancouver, British Columbia – (February 26, 2024) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX, FSE:
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2